Medical Cannabis for Pain: Separating Evidence From Misconceptions | Research

The takeaway

The strongest evidence for medical cannabis exists for chronic pain, neuropathic pain, and MS-related spasticity, but physicians must weigh these benefits against known acute and chronic side effects.

Read this if you want a quick overview of which conditions medical cannabis actually has evidence for and which remain unproven.

Best evidence exists for chronic pain, neuropathic pain, and MS spasticity

What the researchers found

As cannabis policy changes accelerated worldwide, this review addressed the gap between patient expectations and clinical evidence for medical cannabis.

The authors found that the best current evidence supports medical cannabis for three specific conditions: chronic pain, neuropathic pain, and spasticity from multiple sclerosis. For other conditions, the evidence base was weaker or insufficient.

The review also cataloged potential acute and chronic effects of cannabis use that physicians must consider before recommending medical cannabis. These include cognitive effects, psychiatric risks, and dependence potential.

The authors emphasized that increasing patient requests for medical cannabis make it essential for physicians to become knowledgeable about the science and engage in open discussions about both potential benefits and risks.

Why it matters

This review directly addresses the clinical challenge physicians face: patients requesting medical cannabis based on broad claims while the evidence supports only a few specific conditions. It provides a framework for evidence-based conversations between doctors and patients.

The numbers in context

Three conditions with the best current evidence: chronic pain, neuropathic pain, and MS-related spasticity.

How the study worked

Narrative review of current evidence for cannabis and cannabinoids across multiple medical conditions, with assessment of acute and chronic risks of cannabis use.

What this study cannot tell us

Brief narrative review without systematic search methodology or quality assessment. Published in a Polish medical journal, the perspective may emphasize European regulatory context. The rapidly evolving evidence base means some conclusions may have shifted since publication.

How to read the evidence

Concise narrative review of the evidence landscape. Moderate because it accurately reflects the literature but does not conduct systematic analysis.

When this study was published

Published in 2017, reflecting evidence available at that time.

The bigger picture

This review reflects a pivotal moment in medical cannabis history, when changing laws outpaced clinical evidence. The call for physician education on cannabinoid science acknowledges that patient conversations about cannabis are happening regardless of physician preparedness.

Questions still open

Have larger clinical trials since 2017 changed the evidence picture for conditions beyond pain and spasticity? What educational programs have been most effective for physician cannabis literacy? How should physicians handle patient requests for conditions where evidence is weak?

Common questions

What conditions does medical cannabis actually work for?

As of this 2017 review, the strongest evidence supports chronic pain, neuropathic pain, and multiple sclerosis spasticity. For other conditions like anxiety, PTSD, or epilepsy, the evidence was weaker or still being established.

Should doctors recommend medical cannabis?

The authors argue physicians must become knowledgeable about the science and have open conversations with patients about both benefits and risks, rather than either blanket-recommending or dismissing medical cannabis.

Read the original research

Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.

Polish archives of internal medicine, 127(11), 785-789

View on PubMed ↗Publisher’s paper ↗

Citation

Hill, Kevin P; Palastro, Matthew D. (2017). Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.. Polish archives of internal medicine, 127(11), 785-789. https://doi.org/10.20452/pamw.4123